Hypertriglyceridaemia Clinical Trials
2 recruiting trials for Hypertriglyceridaemia. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Hypertriglyceridaemia clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Tokyo Women's Medical University (1), Manchester University NHS Foundation Trust (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Pemafibrate (drug, 1 trial).
Track Hypertriglyceridaemia trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Pemafibrate for Symptomatic ICAS RCT
The goal of this clinical trial is to learn whether pemafibrate can help prevent worsening of intracranial arterial stenosis (ICAS) in patients who have symptomatic ICAS and high...
Abnormal Lipids - Causes and Effects
1. At target LDL-C levels, apoB100 concentrations will be higher than recommended levels in the following populations: 1. Tertiary centre lipid clinic patients with raised TG...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Hypertriglyceridaemia, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Hypertriglyceridaemia, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Hypertriglyceridaemia, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.